• our data Our Data

    Learn what to expect from our database and how our insights can impact your growth

  • Integrations Integrations

    Software that’s built to fit snugly in your company’s technology ecosystem

  • Pricing Pricing

    Read more about our features and plans that are tailor-made for your company’s needs


  • Slintel for Sales Slintel for Sales

    Unleashing your sales team’s true potential is just one software away

  • Slintel for Marketing Slintel for Marketing

    Marketing your product and generating leads shouldn’t be this easy, but it is

  • Technographic Insights Technographic Insights

    Explore a list of 25k+ technologies and get contextual insights on software of your interest

  • Company Insights Company Insights

    Rich, up-to-date information on over 15 million companies, all in one place

  • Technographic Analysis Technographic Analysis

    Compare the common technologies used by up to 251 companies of your choice

  • Compare Technographic Compare Technologies

    See how two software products in the same category compare against each other

  • Resources Center Resource Center

    Ebooks, case studies, and videos to help improve your company revenue

  • Blog Blog

    The Slintelegraph: Stories and content around SalesTech, prospecting, lead gen, and more

  • Guides Guides

    In-depth, long-form content on bleeding edge SalesTech topics

    Buyer Intent right arrow
    Sales Intelligence right arrow
    Technographics right arrow
    Sales Enablement right arrow
Home Home breadcrumbs arrow Company breadcrumbs arrow Inspyr Therapeutics Inc

Inspyr Therapeutics Inc

Inspyr Therapeutics, Inc., formerly GenSpera, Inc., is an integrated biopharmaceutical company. The Company is focused on the development of therapies to treat cancer, inflammation, and other diseases. It operates a technology platform based on adenosine chemistry and biology. Its product pipeline includes Mipsagargin; A2A antagonist; A2B antagonist; A2A agonist, and A2A/A2B Dual Antagonist. The Company is developing Mipsagargin for different tumor types, including Hepatocellular carcinoma (liver cancer), Glioblastoma (brain cancer) and Prostate cancer. The other combinations of Mipsagargin include PD1/PDL1 combination and Xenograft models. The A2A antagonist; A2B antagonist; A2A agonist, and A2A/A2B dual antagonist are its adenosine receptor programs.

  • Headquarters

    San Antonio, Texas, United States

  • Contact



  • Company Size

    1-10 Employees

  • Stock Symbol


  Update my profile

Find 1-10 leads for Inspyr Therapeutics Inc, chat with us today

View on a Computer for a better experience (and more details)
  • Tech Stack
  • Employees
  • Jobs
  • News & Media

Inspyr Therapeutics Inc

We're covering technologies for this company as we speak. We will have an update soon

Employees at Inspyr Therapeutics Inc

Find rich insights on prospects from Inspyr Therapeutics Inc including contact information, interests,skills and more

We don't have enough content for Inspyr Therapeutics Inc employees.

Jobs at Inspyr Therapeutics Inc

Find recent and open job postings from Inspyr Therapeutics Inc

We don't have enough content for Inspyr Therapeutics Inc jobs.

Company News and Alerts

Get news, alerts, and updates about Inspyr Therapeutics Inc

We don't have enough content for Inspyr Therapeutics Inc company news and alerts.


What is Inspyr Therapeutics Inc official website?

The official website of Inspyr Therapeutics Inc is http://www.inspyrtx.com/.

What is Inspyr Therapeutics Inc phone number?

The phone number for Inspyr Therapeutics Inc is 210.479.8112.

How many employees are working at Inspyr Therapeutics Inc?

Slintel keeps track of 1-10 employees who are working at Inspyr Therapeutics Inc.

What industry is Inspyr Therapeutics Inc in?

Inspyr Therapeutics Inc is in the industry of Pharmaceuticals.

Where are Inspyr Therapeutics Inc's headquarters?

Inspyr Therapeutics Inc headquarters are at San Antonio, Texas, United States.